AvT PHARMA SRL
AvT PHARMA reported total assets of 681,930 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of AvT PHARMA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AvT PHARMA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
AvT PHARMA's financial analysis
- Solvency19.7%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AvT PHARMA
AvT PHARMA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.935.935
- VAT number
- BE1004935935
- Peppol
- Registered · 0208:1004935935 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jan 2024
- Registered office
- 1790 Affligem
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
AvT PHARMA (SRL) has been based in Affligem since 2024, active in: business and other management consultancy activities. For 2025, it reports a net profit of 48,207 € and equity of 134,018 €; its revenue is not published. Its solvency stands at 19.7%, below the median of its sector (58.9%).
Companies similar to AvT PHARMA
Companies in the same business, of comparable size and area, outside its group.
- Joyce Verbeke Business and other management consultancy activities Oostkamp · balance sheet 667,831 €
- Lucalex Business and other management consultancy activities Oupeye · balance sheet 677,654 €
- Camelaim B.V. Business and other management consultancy activities Kinrooi · balance sheet 694,946 €
- Prota Business and other management consultancy activities Ghent · balance sheet 660,608 €
- Ceronus Business and other management consultancy activities Heist-op-den-Berg · balance sheet 652,629 €
- Juleo Invest Business and other management consultancy activities Hamme (Vl.) · balance sheet 723,750 €
- Cartheass Business and other management consultancy activities Lanaken · balance sheet 631,897 €
- MLD21 Business and other management consultancy activities Mettet · balance sheet 608,386 €
Frequently asked questions about AvT PHARMA
What is the revenue of AvT PHARMA?
AvT PHARMA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AvT PHARMA?
In Belgium, the VAT number is the company number prefixed with BE: BE1004935935 for AvT PHARMA, if the company is VAT-registered. Its company number (CBE) is 1004.935.935.
Where is the registered office of AvT PHARMA?
According to the CBE register, the registered office of AvT PHARMA is in 1790 Affligem.
What is the equity of AvT PHARMA?
At the close of the 2025 financial year, the equity of AvT PHARMA amounts to 134,018 €, a solvency of 19.7% of total assets.
Who manages AvT PHARMA?
The register lists 1 active mandates at AvT PHARMA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AvT PHARMA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →